G-Protein Coupled Receptor Target Market: By Receptor Type, By Therapeutic Area, By Drug Type, and Geography

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

G-Protein Coupled Receptor (GPCR) Target Market Size, Share, Growth, Trends, and Global Industry Analysis: By Receptor Type (Class A, Class B, Class C, and Others), By Therapeutic Area (Oncology, CNS Disorders, Cardiovascular Diseases, Metabolic Disorders, and Others), By Drug Type (Small Molecules and Biologics), and Region

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

G-Protein Coupled Receptor (GPCR) Target Market size was US$ 3,538.5 million in 2023 and is expected to reach US$ 5,391.3 million in 2030, growing at a CAGR of 6.2% during 2024-2030. GPCRs are the largest and most diverse group of membrane receptors in eukaryotes, playing a crucial role in various physiological processes. The market's growth is driven by several factors: increasing prevalence of chronic diseases, rising investment in drug discovery and development, advancements in GPCR research technologies, and the growing focus on personalized medicine. Additionally, the potential of orphan GPCRs as novel drug targets is creating new opportunities for pharmaceutical companies. However, the GPCR targeting market faces challenges such as the complexity of GPCR signalling pathways, high attrition rates in drug development, and the need for more efficient screening technologies.

G-Protein Coupled Receptor (GPCR) Target Market Key Developments:
  • In August 2022, Sosei Group Corporation and AbbVie announced a new drug development cooperation and option-to-license agreement to identify, develop, and market small compounds modulating novel G protein-coupled receptor (GPCR) targets linked to neurological illness.
  • In December 2022, Sosei Heptares and Eli Lilly launched a drug discovery collaboration to discover, develop, and commercialize small compounds that modify novel G protein-coupled receptor (GPCR) targets related to diabetes and metabolic disorders.

summary download arrow Download Free Sample

G Protein Coupled Receptor Target Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

6.2%

Largest Market

North-America

Fastest Growing Market

Asia-Pacific

G-Protein Coupled Receptor (GPCR) Target Market Dynamics

The GPCR targeting market is experiencing significant growth driven by technological advancements and an increasing understanding of GPCR biology. The emergence of structural biology techniques, such as cryo-electron microscopy, has revolutionized GPCR drug discovery by providing detailed insights into receptor structures and ligand binding mechanisms. This has led to the development of more selective and efficacious GPCR-targeted therapies. Furthermore, the adoption of artificial intelligence and machine learning in drug discovery is accelerating the identification of novel GPCR ligands and potential drug candidates. The market is also seeing a shift towards allosteric modulators and biased agonists, which offer improved safety profiles and reduced side effects compared to traditional orthosteric ligands. Additionally, the growing interest in polypharmacology and multi-target drugs is opening new avenues for GPCR-targeted therapies in complex diseases.

G Protein Coupled Receptor Target Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 3,538.5 million

Market Size in 2030

US$ 5,391.3 million

Market CAGR

6.2%

By Receptor Type

  • Class A
  • Class B
  • Class C
  • Others

By Therapeutic Area

  • Oncology
  • CNS Disorders
  • Cardiovascular Diseases
  • Metabolic Disorders
  • Immunological Disorders
  • Respiratory Diseases
  • Others

By Drug Type

  • Small Molecules
  • Biologics

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030).
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies.
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market.
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market.
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenarios.

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The global G-Protein Coupled Receptor (GPCR) Target market size was US$ 3,538.5 million in 2023 and is expected to reach US$ 5,391.3 million in 2030, growing at a CAGR of 6.2% during the forecast period.

Key drivers include the increasing prevalence of chronic diseases, advancements in GPCR research technologies, rising investment in drug discovery and development, and growing focus on personalized medicine.

Restraints include the complexity of GPCR signalling pathways, high attrition rates in drug development, and challenges in developing selective ligands for closely related receptor subtypes.

The major players in the GPCR targeting market include Pfizer Inc., Merck & Co., Inc., Novartis AG, AstraZeneca plc, and Amgen Inc., among others.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global G Protein Coupled Receptor Target Market Introduction 
2.1.Global G Protein Coupled Receptor Target Market  - Taxonomy
2.2.Global G Protein Coupled Receptor Target Market  - Definitions
2.2.1.Receptor Type
2.2.2.Therapeutic Area
2.2.3.Drug Type
2.2.4.Region
3.Global G Protein Coupled Receptor Target Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global G Protein Coupled Receptor Target Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global G Protein Coupled Receptor Target Market  By Receptor Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Class A
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Class B
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Class C
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Others
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
6.Global G Protein Coupled Receptor Target Market  By Therapeutic Area, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Oncology
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. CNS Disorders
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Cardiovascular Diseases
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Metabolic Disorders
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Immunological Disorders
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
6.6. Respiratory Diseases
6.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.6.3. Market Opportunity Analysis 
6.7. Others
6.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.7.3. Market Opportunity Analysis 
7.Global G Protein Coupled Receptor Target Market  By Drug Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Small Molecules
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Biologics
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
8.Global G Protein Coupled Receptor Target Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America G Protein Coupled Receptor Target Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Receptor Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Class A
9.1.2.Class B
9.1.3.Class C
9.1.4.Others
9.2.  Therapeutic Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Oncology
9.2.2.CNS Disorders
9.2.3.Cardiovascular Diseases
9.2.4.Metabolic Disorders
9.2.5.Immunological Disorders
9.2.6.Respiratory Diseases
9.2.7.Others
9.3.  Drug Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Small Molecules
9.3.2.Biologics
9.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe G Protein Coupled Receptor Target Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Receptor Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Class A
10.1.2.Class B
10.1.3.Class C
10.1.4.Others
10.2.  Therapeutic Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Oncology
10.2.2.CNS Disorders
10.2.3.Cardiovascular Diseases
10.2.4.Metabolic Disorders
10.2.5.Immunological Disorders
10.2.6.Respiratory Diseases
10.2.7.Others
10.3.  Drug Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Small Molecules
10.3.2.Biologics
10.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
11.Asia Pacific (APAC) G Protein Coupled Receptor Target Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Receptor Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Class A
11.1.2.Class B
11.1.3.Class C
11.1.4.Others
11.2.  Therapeutic Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Oncology
11.2.2.CNS Disorders
11.2.3.Cardiovascular Diseases
11.2.4.Metabolic Disorders
11.2.5.Immunological Disorders
11.2.6.Respiratory Diseases
11.2.7.Others
11.3.  Drug Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Small Molecules
11.3.2.Biologics
11.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) G Protein Coupled Receptor Target Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Receptor Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Class A
12.1.2.Class B
12.1.3.Class C
12.1.4.Others
12.2.  Therapeutic Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Oncology
12.2.2.CNS Disorders
12.2.3.Cardiovascular Diseases
12.2.4.Metabolic Disorders
12.2.5.Immunological Disorders
12.2.6.Respiratory Diseases
12.2.7.Others
12.3.  Drug Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Small Molecules
12.3.2.Biologics
12.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America G Protein Coupled Receptor Target Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Receptor Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Class A
13.1.2.Class B
13.1.3.Class C
13.1.4.Others
13.2.  Therapeutic Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Oncology
13.2.2.CNS Disorders
13.2.3.Cardiovascular Diseases
13.2.4.Metabolic Disorders
13.2.5.Immunological Disorders
13.2.6.Respiratory Diseases
13.2.7.Others
13.3.  Drug Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Small Molecules
13.3.2.Biologics
13.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Pfizer Inc.
14.2.2.Merck & Co., Inc.
14.2.3.Novartis AG
14.2.4.AstraZeneca plc
14.2.5.Amgen Inc.
14.2.6.Bristol-Myers Squibb Company
14.2.7.Takeda Pharmaceutical Company Limited
14.2.8.Sanofi S.A.
14.2.9.GlaxoSmithKline plc
14.2.10.Roche Holding AG
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • Pfizer Inc.
  • Merck & Co., Inc.
  • Novartis AG
  • AstraZeneca plc
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • Takeda Pharmaceutical Company Limited
  • Sanofi S.A.
  • GlaxoSmithKline plc
  • Roche Holding AG

Related Industry Reports

Chronic Refractory Gout Pharmaceuticals Market

Familial Mediterranean Fever Pharmaceuticals Market

Australia Point of Care Diagnostics Market

Aseptic Sampling Market